EVOFEM BIOSCIENCES, INC.: operating_income
| Value | {"amount": -34643000, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} |
|---|---|
| Period | 2016-01-01 – 2016-12-31 |
| Status | current |
| Entity | EVOFEM BIOSCIENCES, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T16:39:06.157209+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/bd1de89a-0679-4d6e-a764-a70e9f6da2e7
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-18-110108Retrieved: 2026-08-19T16:39:06.157209+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001618835/operating-income/2016-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/bd1de89a-0679-4d6e-a764-a70e9f6da2e7
History
- supersedes {"amount": -12042300, "concept": "us-gaap:OperatingIncomeLoss", "currency": "USD"} (evidence 0001564590-17-005093)